What HRSA's New Rule Means For Hospitals And Pharma Cos.
On July 23, the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services published a regulation[1] increasing the number of entities to which pharmaceutical manufacturers must sell orphan...To view the full article, register now.
Already a subscriber? Click here to view full article